Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.8211
-0.0757 (-8.44%)
At close: Sep 9, 2026, 4:00 PM EDT
0.8300
+0.0089 (1.08%)
After-hours: Sep 9, 2026, 6:35 PM EDT
Lucid Diagnostics Employees
Lucid Diagnostics had 82 employees as of December 31, 2025. The number of employees increased by 10 or 13.89% compared to the previous year.
Employees
82
Change
10
Growth
13.89%
Revenue / Employee
$66,402
Profits / Employee
-$792,756
Market Cap
156.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 82 | 10 | 13.89% |
| Dec 31, 2024 | 72 | 2 | 2.86% |
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| Neuronetics | 658 |
| InfuSystem Holdings | 473 |
| RxSight | 461 |
| Quanterix | 450 |
| Apyx Medical | 205 |
| Electromed | 197 |
| Profound Medical | 162 |
LUCD News
- 13 days ago - Lucid Diagnostics price target raised to $9.50 from $9.25 at Ascendiant - TheFly
- 22 days ago - Lucid Diagnostics Slides: Corporate presentation - Filings
- 23 days ago - Lucid Diagnostics reports Q2 non-GAAP EPS (6c), consensus (5c) - TheFly
- 26 days ago - PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results - PRNewsWire
- 27 days ago - Lucid Diagnostics Earnings Call Transcript: Q2 2026 - Transcripts
- 27 days ago - Lucid Diagnostics Quarterly report: Q2 2026 - Filings
- 27 days ago - Lucid Diagnostics Earnings release: Q2 2026 - Filings
- 27 days ago - Lucid Diagnostics Slides: Q2 2026 - Filings